StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)

Equities research analysts at StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a report released on Tuesday. The firm set a “hold” rating on the stock.

China Pharma Stock Performance

NYSE CPHI opened at $0.22 on Tuesday. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.51. The company has a 50-day simple moving average of $0.21 and a 200 day simple moving average of $0.21. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.